Viewing Study NCT00698568


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-01-06 @ 4:22 AM
Study NCT ID: NCT00698568
Status: COMPLETED
Last Update Posted: 2008-06-17
First Post: 2008-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module